Omid Yazdani

发表

Epidemiology of COVID-19 in Tehran, Iran: A Cohort Study of Clinical Profile, Risk Factors, and Outcomes

A. Sahebkar, H. Hatamabadi, M. Pourhoseingholi, 2022, BioMed research international.

A randomized clinical trial study on the efficacy and safety of adalimumab and methylprednisolone pulse therapy in the treatment of COVID-19 patients with acute respiratory distress syndrome

E. Hazrati, Ramin Hamidi Farahani, R. Mosaed, 2021, Immunopathologia Persa.

Clinical potential of PD-1/PD-L1 blockade therapy for renal cell carcinoma (RCC): a rapidly evolving strategy

Saba Ilkhani, Romina Esbati, Omid Yazdani, 2022, Cancer cell international.

A comprehensive review of the role of lncRNAs in gastric cancer (GC) pathogenesis, immune regulation, and their clinical applications.

Fatemeh Asadi, A. Adili, F. Ebrahimzadeh, 2022, Pathology, research and practice.

Cytokine sustained delivery for cancer therapy; special focus on stem cell- and biomaterial- based delivery methods.

H. Mehralizadeh, Romina Esbati, Omid Yazdani, 2023, Pathology, research and practice.

A comprehensive survey into the role of exosomes in pancreatic cancer; from the origin of cancer to the progress and possibility of diagnosis and treatment.

A. Adili, M. Alsaffar, Romina Esbati, 2023, Pathology, research and practice.

Diverse activity of miR-150 in Tumor development: shedding light on the potential mechanisms

Romina Esbati, Omid Yazdani, R. D. C. Pecho, 2023, Cancer Cell International.

EZH2-interacting lncRNAs contribute to gastric tumorigenesis; a review on the mechanisms of action.

Romina Esbati, Omid Yazdani, Roozbeh Akhavanfar, 2024, Molecular biology reports.

The role and function of autophagy through signaling and pathogenetic pathways and lncRNAs in ovarian cancer.

Romina Esbati, Omid Yazdani, Yalda Farahmand, 2023, Pathology, research and practice.

miR‐142‐3p/5p role in cancer: From epigenetic regulation to immunomodulation

Yasin Sadeghipour, Romina Esbati, Omid Yazdani, 2024, Cell biochemistry and function.